Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL-Reference-Cited by-同舟云学术

Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL

Published:2018-10 Issue:10 Volume:18 Page:e381-e389
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Li Linyu^ORCID,Zhang Xuhan,Zhang Tingting,Song Zheng,Hu Ge,Li Wei,Li Lanfang,Qiu Lihua,Qian Zhengzi,Zhou Shiyong,Liu Xianming,Feng Lixia,Pan Yi,Zhai Qiongli,Meng Bin,Ren Xiubao,Fu Kai,Wang Ping,Wang Xianhuo,Zhang Huilai

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference24 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview;Sabattini;Pathologica,2010

2. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone;Johnson;J Clin Oncol,2012

3. Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan Chinese;Chen;Cancer,2002

4. The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries;Shiozawa;Leuk Res,2007

5. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL);Klapper;Leukemia,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations;Cytotherapy;2024-07

2. Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment;Cancers;2023-08-15

3. Mitochondrial Peptide Humanin Facilitates Chemoresistance in Glioblastoma Cells;Cancers;2023-08-11

4. Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma;Yonago Acta Medica;2023

5. Obesity and Risk for Lymphoma: Possible Role of Leptin;International Journal of Molecular Sciences;2022-12-08